GleamWall
中文EN

ETST Earth Science Tech, Inc.

Pharmaceutical Preparations · OTC · SEC CIK 1538495 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.1%
TTM net income YoY33.6%
TTM EPS YoY-7.7%
Revenue 3-yr CAGR149.7%
Net income 3-yr CAGR144.1%

Margins

Gross margin70.2%
Operating margin—
Net margin11.0%
FCF margin2.2%
EBITDA margin—

Returns

ROE57.5%
ROA38.5%
ROIC (approx.)—
Asset turnover3.50x

Leverage & solvency

Liabilities / assets25.6%
Debt / equity0.00x
Current ratio1.91x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.43x
Accruals ratio22.0%
Payout ratio—
Capex / revenue2.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302025Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$7.30M$9.03M$9.50M$8.39M$9.05M$8.76M$8.68M$7.35M
Cost of revenue$2.24M$2.75M$3.22M$1.99M$2.33M$2.67M$2.14M$2.27M
Gross profit$5.06M$6.28M$6.27M$6.40M$6.72M$6.09M$6.54M$5.09M
SG&A expense$889,925$1.05M$829,536$914,029$852,712$980,172$699,364$809,850
Operating income———$1.34M———$226,226
Interest expense$9,565$16,197-$8$4,769$7,294$4,272$10,092$6,290
Pretax income$1.11M$958,352$648,336$1.04M$945,897$456,714$1.26M$206,411
Income tax$276,889$242,655-$639,622$127,946——$88,427$0
Net income$831,330$724,192$1.29M$910,376$966,822$465,039$1.17M$206,411
EBITDA———$1.46M———$271,004
EPS (basic)0.000.00—0.000.000.00—0.00
EPS (diluted)0.000.00—0.000.000.00—0.00
Weighted avg. shares (diluted)287.54M290.00M—292.80M293.95M294.51M—302.89M
Banking
Net interest income————-$7,393-$4,272——
Balance sheet
Cash & equivalents$1.01M$631,118$796,797$415,699$1.24M$877,585$1.47M$522,239
Receivables$997,670$845,945$356,054$306,118$227,189$341,644$129,064$164,221
Inventory$913,389$854,074$682,059$1.09M$1.04M$811,859$503,938$137,557
Current assets$4.77M$5.09M$3.72M$3.03M$3.60M$3.08M$3.11M$2.01M
PP&E, net$1.58M$1.50M$1.52M$1.89M$1.86M$1.64M$1.38M$1.12M
Goodwill$2.88M$2.65M$2.65M$2.65M$2.65M$2.65M$2.30M$2.30M
Intangibles$816,017$202,182$208,170$377,684$377,538$184,838$96,885$86,743
Total assets$10.86M$10.37M$8.97M$8.09M$8.67M$7.78M$7.07M$5.71M
Current liabilities$2.50M$2.87M$1.93M$2.26M$3.55M$3.40M$3.15M$2.31M
Short-term debt——————$179,488$30,592
Long-term debt———————$42,785
Total debt———————$73,377
Total liabilities$2.78M$3.01M$1.93M$2.29M$3.59M$3.49M$3.22M$2.43M
Shareholders' equity$8.05M$7.34M$7.01M$5.73M$5.00M$4.24M$3.85M$3.28M
Net debt———————-$448,862
Shares outstanding286.39M287.59M291.32M291.61M292.79M294.30M294.30M302.66M
Cash flow statement
Operating cash flow$137,744$707,131$885,785-$126,118$841,820$339,376$1.99M$500,430
Capital expenditure$652,278$41,417$155,131$17,473$351,795$232,220$296,135$348,435
Free cash flow-$514,534$665,714$730,654-$143,591$490,025$107,156$1.70M$151,995
Investing cash flow$360,541-$480,619-$460,641-$502,948-$272,572-$668,216-$70,459-$1.70M
Financing cash flow-$120,101-$392,191-$44,047-$190,608-$211,459-$266,803-$972,595$191,894
Depreciation & amortization$83,748$66,861-$58,355$121,790$186,398$34,563-$54,250$44,778
Share buybacks$120,101$392,191$5,202$183,184$202,350$80,674$415,999$127,096

Free plan shows the latest 8 periods; Pro shows all 57 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.